相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Heart Matters: Cardiac Dysfunction and Other Autonomic Changes in Parkinson's Disease
Valeria C. Goncalves et al.
NEUROSCIENTIST (2022)
Parkin Deficiency Appears Not to Be Associated with Cardiac Damage in Parkinson's Disease
Michaela Trilck-Winkler et al.
MOVEMENT DISORDERS (2021)
Heart and brain interactions Pathophysiology and management of cardio-psycho-neurological disorders
Renate B. Schnabel et al.
HERZ (2021)
Cardiac tyrosine hydroxylase activation and MB-COMT in dyskinetic monkeys
Lorena Cuenca-Bermejo et al.
SCIENTIFIC REPORTS (2021)
Could Small Heat Shock Protein HSP27 Be a First-Line Target for Preventing Protein Aggregation in Parkinson's Disease?
Javier Navarro-Zaragoza et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Parkinson's disease
Bastiaan R. Bloem et al.
LANCET (2021)
Decreased dynamin-related protein 1-related mitophagy induces myocardial apoptosis in the aging heart
Xin Wei et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2021)
Hidden phenotypes of PINK1/Parkin knockout mice
Swagatika Paul et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2021)
Cardiac 18F-Dopamine PET Distinguishes PD with Orthostatic Hypotension from Parkinsonian MSA
Abhishek Lenka et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2021)
MiR-124 attenuates doxorubicin-induced cardiac injury via inhibiting p66Shc-mediated oxidative stress
Yihai Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Cardiac noradrenaline turnover and heat shock protein 27 phosphorylation in dyskinetic monkeys
Pilar Almela et al.
MOVEMENT DISORDERS (2020)
Post mortem evaluation of inflammation, oxidative stress, and PPARγ activation in a nonhuman primate model of cardiac sympathetic neurodegeneration
Jeanette M. Metzger et al.
PLOS ONE (2020)
Cardiovascular autonomic function testing in multiple system atrophy and Parkinson's disease: an expert-based blinded evaluation
Fabian Leys et al.
CLINICAL AUTONOMIC RESEARCH (2020)
Sicca Symptoms in Parkinson’s Disease: Association with Other Nonmotor Symptoms and Health-Related Quality of Life
Tino Prell et al.
Parkinsons Disease (2020)
Historical Perspective: Models of Parkinson's Disease
Shyh Jenn Chia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
LncRNA MALAT1 targeting miR-124-3p regulates DAPK1 expression contributes to cell apoptosis in Parkinson's Disease
Yi Lu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
MPTP-Induced Impairment of Cardiovascular Function
Xiaoli Liu et al.
NEUROTOXICITY RESEARCH (2020)
Increasing Fatty Acid Oxidation Prevents High-Fat Diet-Induced Cardiomyopathy Through Regulating Parkin-Mediated Mitophagy
Dan Shao et al.
CIRCULATION (2020)
Comparative risk of cardiac arrhythmias associated with acetylcholinesterase inhibitors used in treatment of dementias - A narrative review
Yichang Huang et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2020)
Cardiovascular evaluation of female rats with 6-OHDA-induced parkinsonism: Possible protection by ovarian hormones and participation of nitric oxide
Blenda Hyedra de Campos et al.
LIFE SCIENCES (2020)
Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson's Disease
Shubhra Acharya et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers
Laura Boi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Classical and Delayed Orthostatic Hypotension in Patients With Unexplained Syncope and Severe Orthostatic Intolerance
Parisa Torabi et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Different Circulating Trace Amine Profiles in De Novo and Treated Parkinson's Disease Patients
Giovanni D'Andrea et al.
SCIENTIFIC REPORTS (2019)
Cardiac sympathetic innervation in the MPTP non-human primate model of Parkinson disease
Mar Carmona-Abellan et al.
CLINICAL AUTONOMIC RESEARCH (2019)
Cardiovascular alterations in rats with Parkinsonism induced by 6-OHDA and treated with Domperidone
Lais D. Rodrigues et al.
SCIENTIFIC REPORTS (2019)
Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson's disease
Claudia Carricarte Naranjo et al.
CLINICAL AUTONOMIC RESEARCH (2019)
Dopaminergic neuron injury in Parkinson's disease is mitigated by interfering lncRNA SNHG14 expression to regulate the miR-133b/α-synuclein pathway
Li-Min Zhang et al.
AGING-US (2019)
Animal Models for Parkinson's Disease Research: Trends in the 2000s
Kyohei Kin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Long-term trends in myocardial sympathetic innervation and function in synucleinopathies
Guillaume Lamotte et al.
PARKINSONISM & RELATED DISORDERS (2019)
Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson's Disease: A Systematic Review
Fauze Camargo Maluf et al.
PARKINSONS DISEASE (2019)
Reduced central sympathetic activity in Parkinson's disease
Heidrun H. Kraemer et al.
BRAIN AND BEHAVIOR (2019)
The heart of PD: Lewy body diseases as neurocardiologic disorders
David S. Goldstein et al.
BRAIN RESEARCH (2019)
Alpha-Synuclein in Peripheral Tissues in Parkinson's Disease
Ling-Yan Ma et al.
ACS CHEMICAL NEUROSCIENCE (2019)
MIBG Myocardial Scintigraphy Identifies Premotor PD/DLB During a Negative DAT Scan Period: Second Report
Ryuji Sakakibara et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2019)
Structural and functional alterations of the heart in Parkinson's disease
Jesus Piqueras-Floresa et al.
NEUROLOGICAL RESEARCH (2018)
Beclin-1-Dependent Autophagy Protects the Heart During Sepsis
Yuxiao Sun et al.
CIRCULATION (2018)
Cardiac abnormalities in Parkinson's disease and Parkinsonism
Fulvio A. Scorza et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2018)
Nitric oxide alterations in cardiovascular system of rats with Parkinsonism induced by 6-OHDA and submitted to previous exercise
Lorena de Jager et al.
LIFE SCIENCES (2018)
The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future
Stanley Fahn
PARKINSONISM & RELATED DISORDERS (2018)
Assessment of Atrial Conduction Times in Patients with Newly Diagnosed Parkinson's Disease
Yigit Canga et al.
PARKINSONS DISEASE (2018)
Skin Nerve Phosphorylated alpha-Synuclein Deposits in Parkinson Disease With Orthostatic Hypotension
Vincenzo Donadio et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2018)
Effect of NAC treatment and physical activity on neuroinflammation in subchronic Parkinsonism; is physical activity essential?
Ana-Luisa Gil-Martinez et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Patients with Parkinson disease present high ambulatory blood pressure variability
Helcio Kanegusuku et al.
CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING (2017)
Past, Present, and Future of Parkinson's Disease: A Special Essay on the 200th Anniversary of the Shaking Palsy
J. A. Obeso et al.
MOVEMENT DISORDERS (2017)
The catechol-O-methyltransferase inhibitors tolcapone and entacapone uncouple and inhibit the mitochondrial respiratory chain in HepaRG cells
David Grunig et al.
TOXICOLOGY IN VITRO (2017)
The long noncoding RNA HOTAIR promotes Parkinson's disease by upregulating LRRK2 expression
Sheng Wang et al.
ONCOTARGET (2017)
Neuropathological Staging of Brain Pathology in Sporadic Parkinson's disease: Separating the Wheat from the Chaff
Heiko Braak et al.
JOURNAL OF PARKINSONS DISEASE (2017)
Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia
Nagaendran Kandiah et al.
CLINICAL INTERVENTIONS IN AGING (2017)
Parkinson's disease-related DJ-1 functions in thiol quality control against aldehyde attack in vitro
Noriyuki Matsuda et al.
SCIENTIFIC REPORTS (2017)
Circulating Long Noncoding RNA HOTAIR is an Essential Mediator of Acute Myocardial Infarction
Lu Gao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease
Christel Renoux et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Supine hypertension in Parkinson's disease and multiple system atrophy
Alessandra Fanciulli et al.
CLINICAL AUTONOMIC RESEARCH (2016)
Drugs with potential cardiac adverse effects: Retrospective study in a large cohort of parkinsonian patients
A. Heranval et al.
REVUE NEUROLOGIQUE (2016)
Evaluation of Cardiac Autonomic Functions in Older Parkinson's Disease Patients: a Cross-Sectional Study
Ahmet Yalcin et al.
AGING AND DISEASE (2016)
Dysautonomias in Parkinson's disease: cardiovascular changes and autonomic modulation in conscious rats after infusion of bilateral 6-OHDA in substantia nigra
D. Ariza et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)
Lesion of the locus coeruleus aggravates dopaminergic neuron degeneration by modulating microglial function in mouse models of Parkinson's disease
Ning Yao et al.
BRAIN RESEARCH (2015)
Risks of Cardiac Valve Regurgitation and Heart Failure Associated with Ergot- and Non-Ergot-Derived Dopamine Agonist Use in Patients with Parkinson's Disease: A Systematic Review of Observational Studies
Tanja Tran et al.
CNS DRUGS (2015)
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype
Paolo Solla et al.
JOURNAL OF NEURAL TRANSMISSION (2015)
Cardiovascular and autonomic alterations in rats with Parkinsonism induced by 6-OHDA and treated with L-DOPA
A. S. Silva et al.
LIFE SCIENCES (2015)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
Chemoreflex and baroreflex alterations in Parkinsonism induced by 6-OHDA in unanesthetized rats
Deborah Ariza et al.
NEUROSCIENCE LETTERS (2015)
Parkinson's disease proteins: Novel mitochondrial targets for cardioprotection
Uma A. Mukherjee et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Metalloproteinase-9 contributes to inflammatory glia activation and nigro-striatal pathway degeneration in both mouse and monkey models of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism
V. Annese et al.
BRAIN STRUCTURE & FUNCTION (2015)
Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease
Chandana Buddhala et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients
Santiago Perez-Lloret et al.
EXPERT OPINION ON DRUG SAFETY (2014)
Heart failure having little effect on the progression of Parkinson's disease: Direct evidence from mouse model
Jing Xu et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Cardiovascular effects of levodopa in Parkinson's disease
Cornelia Noack et al.
PARKINSONISM & RELATED DISORDERS (2014)
Postprandial hypotension in de novo Parkinson's disease: A comparison with orthostatic hypotension
Tadashi Umehara et al.
PARKINSONISM & RELATED DISORDERS (2014)
Cardiac Sympathetic Denervation in 6-OHDA-Treated Nonhuman Primates
Valerie Joers et al.
PLOS ONE (2014)
DJ-1 protects against cell death following acute cardiac ischemia-reperfusion injury
R. K. Dongworth et al.
CELL DEATH & DISEASE (2014)
Stable overexpression of DJ-1 protects H9c2 cells against oxidative stress under a hypoxia condition
Hai-Hong Yu et al.
CELL BIOCHEMISTRY AND FUNCTION (2013)
Outcomes of screening Parkinson's patients for QTc prolongation
Anne-Louise Cunnington et al.
PARKINSONISM & RELATED DISORDERS (2013)
Alpha-synuclein aggregates in epicardial fat tissue in living subjects without parkinsonism
Judith Navarro-Otano et al.
PARKINSONISM & RELATED DISORDERS (2013)
Autonomic disorders predicting Parkinson's disease
Jose-Alberto Palma et al.
PARKINSONISM & RELATED DISORDERS (2013)
Correction: Loss of PINK1 Increases the Heart's Vulnerability to Ischemia-Reperfusion Injury
Hilary K. Siddall et al.
PLoS One (2013)
Parkinson-susceptibility gene DJ-1/PARK7 protects the murine heart from oxidative damage in vivo
Filio Billia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
PINK1-Phosphorylated Mitofusin 2 Is a Parkin Receptor for Culling Damaged Mitochondria
Yun Chen et al.
SCIENCE (2013)
Hypoxic preconditioning up-regulates DJ-1 protein expression in rat heart-derived H9c2 cells through the activation of extracellular-regulated kinase 1/2 pathway
Hai-Shan Lu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Nonuniform Cardiac Denervation Observed by 11C-meta-Hydroxyephedrine PET in 6-OHDA-Treated Monkeys
Valerie Joers et al.
PLOS ONE (2012)
The Dementia of Cardiac Disease
Hurmina Muqtadar et al.
CURRENT CARDIOLOGY REPORTS (2012)
Prevalence of orthostatic hypotension in Parkinson's disease: A systematic review and meta-analysis
Daan C. Velseboer et al.
PARKINSONISM & RELATED DISORDERS (2011)
PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function
Filio Billia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease
C. Barcia et al.
CELL DEATH & DISEASE (2011)
Nondipping in Parkinson's Disease
Sita Sommer et al.
PARKINSONS DISEASE (2011)
The progression of pathology in Parkinson's disease
Glenda Margaret Halliday et al.
YEAR IN NEUROLOGY 2 (2010)
PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy
Noriyuki Matsuda et al.
JOURNAL OF CELL BIOLOGY (2010)
Vulnerability of peripheral catecholaminergic neurons to MPTP is not regulated by α-synuclein
Marife Cano-Jaimez et al.
NEUROBIOLOGY OF DISEASE (2010)
The cause of death in idiopathic Parkinson's disease
Susan Pennington et al.
PARKINSONISM & RELATED DISORDERS (2010)
Subtle Cardiovascular Dysfunction in the Unilateral 6-Hydroxydopamine-Lesioned Rat
K. Slack et al.
PARKINSONS DISEASE (2010)
Diminished tyrosine hydroxylase immunoreactivity in the cardiac conduction system and myocardium in Parkinson's disease: an anatomical study
Estifanos Ghebremedhin et al.
ACTA NEUROPATHOLOGICA (2009)
Cardiac parasympathetic dysfunction concurrent with cardiac sympathetic denervation in Parkinson's disease
Mamoru Shibata et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Multipoint analysis of reduced 125I-meta-iodobenzylguanidine uptake and norepinephrine turnover in the hearts of mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine-induced parkinsonism
Nobuyoshi Fukumitsu et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
Thorough QT/QTc Study in Patients With Advanced Parkinson's Disease: Cardiac Safety of Rotigotine
M. Malik et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Adrenergic supersensitivity in Parkinsonians with orthostatic hypotension
J. M. SENARD et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)
Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease
Hiroshige Fujishiro et al.
MOVEMENT DISORDERS (2008)
Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension
Yehonatan Sharabi et al.
MOVEMENT DISORDERS (2008)
Second consensus statement on the diagnosis of multiple system atrophy
S. Gilman et al.
NEUROLOGY (2008)
Myocardial nerve fibers are preserved in MPTP-treated mice, despite cardiac sympathetic dysfunction
Takeshi Amino et al.
NEUROSCIENCE RESEARCH (2008)
Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery
Yufeng Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
Kelly Claire Simon et al.
NEUROLOGY (2007)
Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism
Anne-Sophie Rolland et al.
BRAIN (2007)
The Parkinsonian heart: From novel vistas to advanced therapeutic approaches in Parkinson's disease
Francesco Fornai et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and L-DOPA in the rat
J. P. M. Finberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2
Casey M. Clements et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Quantitation of cardiac sympathetic innervation in rabbits using 11C-hydroxyephedrine PET:: relation to 123I-MIBG uptake
Yusuke Nomura et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Reduced I-125-meta-iodobenzylguanidine uptake and norepinephrine transporter density in the hearts of mice with MPTP-induced parkinsonism
N Fukumitsu et al.
NUCLEAR MEDICINE AND BIOLOGY (2006)
Parkinson's disease, stroke, and related epidemiology
A Nataraj et al.
MOVEMENT DISORDERS (2005)
The effects of acute loading with levodopa and levodopa with selegiline on blood pressure and plasma norepinephrine levels in chronic Parkinson's disease patients
R Stryjer et al.
ACTA NEUROLOGICA SCANDINAVICA (2005)
Profound cardiac sympathetic denervation occurs in Parkinson disease
T Amino et al.
BRAIN PATHOLOGY (2005)
Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease
G Van Camp et al.
LANCET (2004)
Severe multivalvular heart disease: A new complication of the ergot derivative dopamine agonists
J Horvath et al.
MOVEMENT DISORDERS (2004)
Heart failure in Parkinson's disease: analysis of the United States medicare current beneficiary survey
TA Zesiewicz et al.
PARKINSONISM & RELATED DISORDERS (2004)
Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD
S Saiki et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2004)
Heart valvular disease in patients with Parkinson's disease treated with high-dose pergolide
G Van Camp et al.
NEUROLOGY (2003)
Sympathetic innervation in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease
DS Goldstein et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Association between supine hypertension and orthostatic hypotension in autonomic failure
DS Goldstein et al.
HYPERTENSION (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy
S Orimo et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
Progressive loss of cardiac sympathetic innervation in Parkinson's disease
ST Li et al.
ANNALS OF NEUROLOGY (2002)
Orthostatic hypotension from sympathetic denervation in Parkinson's disease
DS Goldstein et al.
NEUROLOGY (2002)
Significant reduction of 125I-meta-iodobenzylguanidine accumulation directly caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine, a toxic agent for inducing experimental Parkinson's disease
H Takatsu et al.
NUCLEAR MEDICINE COMMUNICATIONS (2002)
Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA
S Orimo et al.
NEUROLOGY (2001)
Depressed baroreflex sensitivity in patients with Alzheimer's and Parkinson's disease
T Szili-Török et al.
NEUROBIOLOGY OF AGING (2001)
Orthostatic hypotension in patients with Parkinson's disease - Pathophysiology and management
JM Senard et al.
DRUGS & AGING (2001)
Heart rate variability in Parkinson's disease patients treated with tolcapone
G Meco et al.
PARKINSONISM & RELATED DISORDERS (2000)
Cardiac sympathetic denervation in Parkinson disease
DS Goldstein et al.
ANNALS OF INTERNAL MEDICINE (2000)
Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific
J Taki et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)
Scintigraphic differentiation between two forms of primary dysautonomia early after onset of autonomic dysfunction:: value of cardiac and pulmonary iodine-123 MIBG uptake
MJ Reinhardt et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)
分享论文
